KEVZARA
KEVZARA
Approved
DIN Number
02472961
Drug Class
Human
Market Date
Jun 21, 2018
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02472961
AIG Number0158770001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC14 SARILUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SARILUMABActive
Strength: 150 MG / 1.14 ML
Monograph: SARILUMAB